Searched for
TRASTUZUMAB DERUXTECAN PRICE
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...- GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...
- NPPA asks companies to cut prices of three cancer drugs post tax reliefIn a move aimed at providing relief to cancer patients, the National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturer...
- From tax tweaks to job incentive scheme, 25 key announcements by Nirmala Sitharaman in Union Budget 2024-25Budget 2024 Key Takeaways: Presenting the Budget, Finance minister Nirmala Sitharaman unveiled a host of significant booster for sectors su...
- Budget 2024 Decoded: Your 2 minute guide to become a budget proBudget Decoded: Finance Minister Nirmala announced a host of steps for the economy, companies, markets and taxpayers in the Budget 2024. He...
- AstraZeneca bets on licencing deals, public-private partnerships for India growthBritish-Swedish drugmaker AstraZeneca is set to launch 15 new products in India from 2023 to 2025, focusing on oncology, cardiovascular, re...
Load More